Indications
Prevention of cholera in epidemic, endemic or humanitarian emergency contexts
PDF page 514
Loading InternPractice…
Drug reference
Prevention of cholera in epidemic, endemic or humanitarian emergency contexts
PDF page 514
Do not administer to children less than one year. Do not administer in the event of hypersensitivity to any component of the vaccine or history of an allergic reaction to a previous dose. Vaccination should be postponed in the event of severe acute febrile illness; minor infections are not contra-indications. May cause: nausea, vomiting, abdominal cramping, diarrhoea. Drinking water after swallowing the vaccine may reduce its unpleasant taste and prevent vomiting. If the patient vomits the dose of vaccine, wait for 10 minutes and re-administer the same dose and follow with a larger volume of water. Pregnancy: can be administered (the benefits outweigh the risks). Breast-feeding: no contra-indication
PDF page 514
Inactivated whole cell bivalent vaccine containing Vibrio cholerae O1 (serotypes Inaba and Ogawa, and biotypes classical and El Tor) and Vibrio cholerae O139 Oral suspension, 1.5 ml in monodose plastic tube. DO NOT ADMINISTER BY PARENTERAL ROUTE.
PDF page 514
Child 1 year and over and adult: 2 doses of 1.5 ml administered at least 14 days apart In certain contexts (e.g. outbreak and limited number of vaccines), a single dose of 1.5 ml is administered. Shake the vial, squirt the entire contents of the vial into the mouth. For young children, the contents of the vial can be drawn up in a syringe and squirted into the mouth.
PDF page 514
Immunity develops one week after administration and lasts up to 6 months after a single dose and at least 3 years after 2 doses.
PDF page 514
– Between 2 °C and 8 °C. Do not freeze; discard if vaccine has been frozen. ® Shanchol vaccines used in controlled temperature chain (CTC) can be stored at temperatures of up to 40 °C for 14 days maximum. All vaccines removed from the cold chain and not used within 14 days or exposed to temperatures > 40 °C must be discarded.
PDF pages 514, 515
2 doses of 1.5 ml administered at least 14 days apart
PDF page 514